Director, Nonclinical Due Diligence & External Innovation

CSL Behring Vifor seeks a Director for Nonclinical Due Diligence & External Innovation in EMEA (CH). The role provides scientific leadership for in-licensing and acquisition evaluations, reporting to the Executive Director of Nonclinical Development.

This position serves as the primary scientific authority for nonclinical assessments tied to in-licensing, acquisitions, and strategic partnerships. The director ensures that pharmacology, PK/QSP, and toxicology data are evaluated objectively to support high-stakes business decisions. Additionally, the role acts as the nonclinical liaison for specific research programs and oversees strategy across therapeutic areas.

Responsibilities

• Manages the full lifecycle of nonclinical due diligence for assigned opportunities, from initial request to final governance presentation.
• Synthesizes expert input from toxicology, PK/QSP, and pharmacology teams into a unified scientific assessment.
• Translates complex data into clear risk narratives and identifies First-in-Human (FIH) enabling gaps, translational risks, and regulatory constraints.
• Develops high-quality due diligence reports, executive summaries, and risk tables for governance review.
• Serves as the scientific interface between Nonclinical Development and Business Development/Therapeutic Area teams.
• Chairs the NCD Review Committee and escalates high-impact issues to the Head of NCD.
• Maintains and improves nonclinical due diligence frameworks and templates.
• Mentors junior team members and matrix contributors as needed.

Requirements

• Advanced degree (Ph.D., D.V.M., or equivalent) in toxicology, pharmacology, or a related discipline.
• Over 10 years of experience in nonclinical development, with demonstrated expertise in due diligence or external innovation.
• Deep understanding of First-in-Human (FIH) enabling requirements, especially for biologics and complex modalities.
• Strong knowledge of the drug development process and ICH/GLP standards.
• Fluent proficiency in English, both written and spoken.

Nice to have

• Board certification in toxicology.
• Experience spanning multiple therapeutic areas and modalities.

What the company offers

• Access to CSL benefits and well-being support resources.

About the company

CSL Behring is a global leader in biotherapeutics, employing 32,000 people who deliver lifesaving therapies to patients in over 100 countries. The organization is driven by a mission to save lives, with inclusion and belonging at its core. This culture fosters innovation through curiosity and empathy.

• Commitment to inclusion and belonging to fuel innovation.
• Global impact with therapies reaching more than 100 countries.
• Culture built on curiosity and empathy.